Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalsan You

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Korean Journal of Urology|March 13, 2015
Clinicopathological features of Xp11.2 translocation renal cell carcinomaBumjin Lim, Dalsan You, In Gab Jeong, et al.
Korean Journal of Urology|December 24, 2013
Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomySahyun Pak, Sejun Park, Jeman Ryu, et al.
Scientific Reports|May 7, 2025
Comparative analysis of oncologic outcomes in surgically treated patients with renal cell carcinoma and renal vein thrombosis by pathologic subtypesDongrul Shin, Bumjin Lim, Cheryn Song, et al.
BMC Cancer|March 11, 2018
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control studyMyong Kim, Cheryn Song, In Gab Jeong, et al.
Kidney Research and Clinical Practice|December 12, 2019
Clinical features and outcomes in kidney transplant recipients with renal cell carcinoma: a single-center studyKeun Hoi Park, Jung A Yoon, Hak Soo Kim, et al.
International Journal of Stem Cells|November 30, 2018
Hypoxic Preconditioned Mesenchymal Stromal Cell Therapy in a Rat Model of Renal Ischemia-reperfusion Injury: Development of Optimal Protocol to Potentiate Therapeutic EfficacyMyoung Jin Jang, Dalsan You, Jin Young Park, et al.
Scientific Reports|March 4, 2022
miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinomaSang Eun Park, Wonju Kim, Ji-Ye Hong, et al.
Cancer Research and Treatment|July 8, 2020
Cause of Mortality after Radical Prostatectomy and the Impact of Comorbidity in Men with Prostate Cancer: A Multi-institutional Study in KoreaSahyun Pak, Dalsan You, In Gab Jeong, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2015
Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitorInkeun Park, Jae-Lyun Lee, Jin-Hee Ahn, et al.
The Journal of Urology|June 25, 2013
Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomiesIn Gab Jeong, Ju Hyun Lim, Dalsan You, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Korean Journal of Urology|March 13, 2015
Clinicopathological features of Xp11.2 translocation renal cell carcinomaBumjin Lim, Dalsan You, In Gab Jeong, et al.
Korean Journal of Urology|December 24, 2013
Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomySahyun Pak, Sejun Park, Jeman Ryu, et al.
Scientific Reports|May 7, 2025
Comparative analysis of oncologic outcomes in surgically treated patients with renal cell carcinoma and renal vein thrombosis by pathologic subtypesDongrul Shin, Bumjin Lim, Cheryn Song, et al.
BMC Cancer|March 11, 2018
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control studyMyong Kim, Cheryn Song, In Gab Jeong, et al.
Kidney Research and Clinical Practice|December 12, 2019
Clinical features and outcomes in kidney transplant recipients with renal cell carcinoma: a single-center studyKeun Hoi Park, Jung A Yoon, Hak Soo Kim, et al.
International Journal of Stem Cells|November 30, 2018
Hypoxic Preconditioned Mesenchymal Stromal Cell Therapy in a Rat Model of Renal Ischemia-reperfusion Injury: Development of Optimal Protocol to Potentiate Therapeutic EfficacyMyoung Jin Jang, Dalsan You, Jin Young Park, et al.
Scientific Reports|March 4, 2022
miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinomaSang Eun Park, Wonju Kim, Ji-Ye Hong, et al.
Cancer Research and Treatment|July 8, 2020
Cause of Mortality after Radical Prostatectomy and the Impact of Comorbidity in Men with Prostate Cancer: A Multi-institutional Study in KoreaSahyun Pak, Dalsan You, In Gab Jeong, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2015
Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitorInkeun Park, Jae-Lyun Lee, Jin-Hee Ahn, et al.
The Journal of Urology|June 25, 2013
Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomiesIn Gab Jeong, Ju Hyun Lim, Dalsan You, et al.
Pageof 17